Dr. Michael S. Strobbe, DO

Dr. Strobbe practices at Gulf Coast Medical Center Port Richey North - Urgent Care in Port Richey, Florida.

Dr. Strobbe's NPI, 1437125002, was assigned on February 24, 2006. Dr. Strobbe graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2004. Dr. Strobbe holds Florida license OS9717.

Dr. Strobbe's primary practice is Gulf Coast Medical Center Port Richey North - Urgent Care, at 11528 Us Highway 19, Port Richey, FL 34668. The practice phone is (727) 868-2151.

Dr. Strobbe's primary practice is Gulf Coast Medical Center Port Richey North - Urgent Care in Port Richey, Florida. Dr. Strobbe is also affiliated with HCA Florida Bayonet Point Hospital. The medical group on file is Gulf Coast Medical Center. Dmand AI also links Dr. Strobbe to 2 more hospitals, 5 home health agencies, 2 group practices and clinics, 1 therapy and rehab clinic and 1 medical group, each named with a free account. Dr. Strobbe's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Strobbe practices, 12 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Strobbe's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Strobbe is board certified in internal medicine by the AOA Board of Internal Medicine. Dr. Strobbe is licensed in Florida.

Dmand AI lists acid reflux, acute diabetes, acute kidney failure, acute sinusitis, acute skin infection, ADHD, alzheimer's disease and anemia among the conditions Dr. Strobbe treats.

CMS data shows 8,080 Medicare services from Dr. Strobbe across 48 procedure codes in 2024, for 978 Medicare patients. Medicare paid $375,893 for them.

CMS counts 978 Medicare patients who saw Dr. Strobbe in 2024. The largest group is 65 to 74, with 447 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Strobbe's median patient age at 64, with 54% women.

In 2024, Dr. Strobbe wrote 24,864 Medicare Part D claims for 1,437 patients. 86% of them were for generic drugs. CMS names the drug for 23,839 of them, across 244 drugs with 11 or more claims each, at $2,241,862 in total drug cost. In 2023, CMS named 25,215 claims across 253 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Strobbe for performance year 2024, reported as part of a group. Dr. Strobbe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Strobbe as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Strobbe in 2025. Dr. Strobbe's most frequent co-authors are Philip Marc Brunetti, MD, Jack Russell Lubka, MD and Jeffrey Scott Mino, MD.

CMS Open Payments shows 364 general payments to Dr. Strobbe from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,117.

Dmand AI lists 6 awards for Dr. Strobbe, most recently NCQA DRP in 2014.

Dr. Strobbe graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2004. Dr. Strobbe is a member of AOA.

Dr. Strobbe is in network with 13 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.